Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hyperthermia × Fluorouracil × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 35 Pancreatic Neoplasms 26 Rectal Neoplasms 15 Esophageal Neoplasms 13 Colonic Neoplasms 12 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 8 Gastrointestinal Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Adenocarcinoma Of Esophagus 7 Neoplasms 6 Head and Neck Neoplasms 5 Carcinoma, Squamous Cell 5 Carcinoma, Non-Small-Cell Lung 5 Biliary Tract Neoplasms 5 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Melanoma 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Solid Tumor 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Diseases 2 Endometrial Neoplasms 2

Interventions

Diathermy 2 tislelizumab 1 spartalizumab 1 Radiotherapy 1 Oxaliplatin 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡